Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,430 | -17,790 | -22,190 | 0 | 0 |
| Depreciation Amortization | 170 | 210 | 310 | 0 | 0 |
| Other Working Capital | -2,010 | 1,250 | 4,780 | 0 | 0 |
| Other Operating Activity | 630 | 920 | -910 | -12,400 | -10,710 |
| Operating Cash Flow | $-14,640 | $-15,410 | $-18,010 | $-12,400 | $-10,710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -60 | 3,340 | -30 | -230 |
| Investing Cash Flow | $-9 | $-60 | $3,340 | $-30 | $-230 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 8,640 | 15,190 | 22,810 | 110 |
| Financing Cash Flow | $0 | $8,640 | $15,190 | $22,810 | $110 |
| Exchange Rate Effect | -1,400 | 5,290 | -4,220 | -3,580 | 730 |
| Beginning Cash Position | 28,520 | 25,720 | 34,500 | 25,900 | 32,740 |
| End Cash Position | 12,460 | 24,180 | 30,800 | 32,690 | 22,640 |
| Net Cash Flow | $-16,050 | $-1,530 | $-3,690 | $6,780 | $-10,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,640 | -15,410 | -18,010 | -12,400 | -10,710 |
| Free Cash Flow | -14,640 | -15,410 | -18,010 | -12,400 | -10,710 |